These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation. Bodewes FA; Verkade HJ; Taminiau JA; Borowitz D; Wilschanski M; J Cyst Fibros; 2015 Mar; 14(2):169-77. PubMed ID: 25677689 [TBL] [Abstract][Full Text] [Related]
12. To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool. Suzuki H United European Gastroenterol J; 2019 Aug; 7(7):873-874. PubMed ID: 31428410 [No Abstract] [Full Text] [Related]
13. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Robertson MB; Choe KA; Joseph PM Radiographics; 2006; 26(3):679-90. PubMed ID: 16702447 [TBL] [Abstract][Full Text] [Related]
14. Gastro-intestinal manifestations in cystic fibrosis patients. Van Biervliet S; de Clercq C; Declercq D; Van Braeckel E; Van Daele S; De Baets F; De Looze D Acta Gastroenterol Belg; 2016; 79(4):481-486. PubMed ID: 28209107 [TBL] [Abstract][Full Text] [Related]
16. Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis. Sathe M; Sharma PB; Savant AP Pediatr Pulmonol; 2021 Oct; 56(10):3120-3125. PubMed ID: 34310872 [TBL] [Abstract][Full Text] [Related]